Why the study?
The study was conducted to describe three clinical cases of pediatric patients with dilated cardiomyopathy and analyze their genetic causes.
Pathogenic variants in the RBM20 gene are associated with severe dilated cardiomyopathy with childhood onset.
Answers are grounded in this paper and cite their sources.
RBM20 variants may contribute to pediatric DCMP; hypothesis-generating and leaves open larger validation studies before screening changes.
Aim. Description of three clinical cases of pediatric patients with dilated cardiomyopathy (DCMP) and an analysis of their genetic causes. Material and methods . Using the method of targeted sequencing, data were obtained on the presence of pathogenic variants of the RBM20 gene in three pediatric patients with DCMP. Results. Three cases of childhood DCMP development, associated with structural disorders in the RBM20 gene, are particularly described. It is known that RBM20 is involved in the splicing of mRNA of the TTN gene encoding the titin protein. A splicing disorder associated with pathogenic variants in the RBM20 gene can lead to a change in biomechanical and signaling processes in myocardial cells, causing pathological dilated remodeling and rhythm disorders. Conclusion . Variants in the RBM20 gene are associated with severe DCMP with a childhood debut. In some cases, the progression of RBM20-associated cardiomyopathies is associated with an infectious disease. Further study of the molecular mechanisms of the pathogenesis of DCMP associated with pathogenic variants in the TTN and RBM20 genes is extremely relevant for both clinical cardiology and fundamental medicine.
No takes yet. Share an insight, caveat, or question.
Kiselev et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: